BELLICUM PHARMACEUTICALS, INC Quarterly Common Stock, Shares Authorized from Q4 2014 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Bellicum Pharmaceuticals, Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2014 to Q3 2023.
  • Bellicum Pharmaceuticals, Inc Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 160M shares, a 100% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 160M +80M +100% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 160M +80M +100% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 160M +80M +100% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 160M +80M +100% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 80M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 80M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 80M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 80M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 80M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 80M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 80M +40M +100% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 80M 0 0% Dec 31, 2020 10-K 2022-03-24
Q3 2020 80M -120M -60% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 80M -120M -60% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 40M -160M -80% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 80M +40M +100% Dec 31, 2019 10-K 2021-03-31
Q3 2019 200M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 200M 0 0% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 200M 0 0% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 40M -160M -80% Dec 31, 2018 10-K 2020-03-12
Q3 2018 200M 0 0% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 200M 0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 200M 0 0% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 200M 0 0% Dec 31, 2017 10-K 2019-03-12
Q3 2017 200M 0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 200M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 200M 0 0% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 200M 0 0% Dec 31, 2016 10-K 2018-03-13
Q3 2016 200M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 200M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 200M 0 0% Dec 31, 2015 10-K 2017-03-13
Q3 2015 200M Sep 30, 2015 10-Q 2015-11-09
Q2 2015 200M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 200M Mar 31, 2015 10-Q 2015-05-12
Q4 2014 200M Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.